BASSLER BONNIE L sold 32.9% of their position (760.00 shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $570.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2025ACC: 0001683607-25-000006
Director
Since Jan 2019
-760.00
Net shares
Net seller
$570.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
760.00 acquired · 1.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+760.00
Price / share
$371.40
Trade value
$282.26K
% of position
49.1%
11/20/2025
1.55K→2.31K
Common Stock
Direct
Shares
−760.00
Price / share
$750.00
Trade value
$570K
% of position
32.9%
11/20/2025
2.31K→1.55K
Total
Net shares
+0.00
Net value
-$287.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2025 | M · Option Exercise | +760.00 | $371.40 | $282.26K | 49.1% | 1.55K | 2.31K |
| Common Stock Direct | 11/20/2025 | S · Sale | −760.00 | $750.00 | $570K | 32.9% | 2.31K | 1.55K |
| Total | +0.00 | -$287.74K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
760.00 shares
Shares
−760.00
Strike price
371.4
Held after
756.00
Exercisable
—
11/20/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock760.00 shares | 11/20/2025 | M · Option Exercise | −760.00 | 371.4 | — | 756.00 |